Pharmaceuticals, Biotechnology and Life Sciences
The publication of the 2018 Annual Report marks the public debut ofNovocure’s newly defined vision, mission and values. Novocure launchedits vision, mission and values internally to its nearly 600 employees atthe end of 2018.
The primary endpoint is the percent reduction in urinary oxalate frombaseline to six months. The Company expects to report initialILLUMINATE-B results in mid-2020.
standalone implantation of two iStent®Trabecular Micro-Bypass Stents in newly diagnosed primary open-angleglaucoma (POAG) eyes achieved a 35.3% reduction in meanintraocular pressure (IOP) to 16.5 mmHg after five years of follow-up.
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that it has expanded its existing…
DUBLIN–(BUSINESS WIRE)–The “US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025” report has been added to ResearchAndMarkets.com’s offering. “US…
DUBLIN–(BUSINESS WIRE)–The “Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to…
San Diego-based Allele Biotechnology and Pharmaceuticals, Inc.,officially announced a joint research and development agreement withSouth Korea’s SCM Lifescience Co., Ltd., for the development of diabetestherapies using pancreatic beta cells derived from induced pluripotentstem cells (iPSCs).
DUBLIN–(BUSINESS WIRE)–The “Drugs of Abuse Testing: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. Report Scope An…
Global Markets to 2023 with Abbott Laboratories, Bayer Healthcare, GlaxoSmithKline, Merck & Co, Pfizer and Sanofi at the Forefront